smecta orange-vanilla flavour powder for oral suspension 3g
ep plus group sdn. bhd. - diosmectite -
forlax 10g powder for oral solution
ep plus group sdn. bhd. - macrogol 4,000 -
ginkor fort capsules
beaufour ipsen industrie - ginkgo biloba extract, troxerutin, heptaminol hydrochloride - capsules - 14mg+ 300mg+ 300mg
ginkor fort capsule
ep plus group sdn. bhd. - ginkgo biloba extract; heptaminol hydrochloride; troxerutin -
forlax 4g powder for oral solution
ep plus group sdn. bhd. - macrogol 4,000 -
increlex
ipsen pharma - mecasermin - laron syndrome - pituitary and hypothalamic hormones and analogues - for the long-term treatment of growth failure in children and adolescents with severe primary insulin-like-growth-factor-1 deficiency (primary igfd).severe primary igfd is defined by:height standard deviation score ≤ -3.0 and;basal insulin-like growth factor-1 (igf-1) levels below the 2.5th percentile for age and gender and;growth hormone (gh) sufficiency;exclusion of secondary forms of igf-1 deficiency, such as malnutrition, hypothyroidism, or chronic treatment with pharmacologic doses of anti-inflammatory steroids.severe primary igfd includes patients with mutations in the gh receptor (ghr), post-ghr signalling pathway, and igf-1 gene defects; they are not gh deficient, and therefore, they cannot be expected to respond adequately to exogenous gh treatment. it is recommended to confirm the diagnosis by conducting an igf-1 generation test.
tanakan 40mg tablets film-coated
beaufour ipsen industrie - ginkgo biloba extract - tablets film-coated - 40mg
forlax 10g powder for oral solution
beaufour ipsen industrie - macrogol (macrogol 4000) - powder for oral solution - 10g
intetrix 50mg+50mg+200mg capsules
beaufour ipsen industrie - tiliquinol, tiliquinol-n-dodecyl sulfate, tilbroquinol - capsules - 50mg+50mg+200mg
smecta 3g powder for oral suspension with orange flavour
beaufour ipsen industrie - diosmectite - powder for oral suspension with orange flavour - 3g